Published in Infect Dis Ther on March 29, 2017
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med (2007) 10.40
Multistate point-prevalence survey of health care-associated infections. N Engl J Med (2014) 8.78
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med (2007) 7.91
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis (2006) 5.27
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2015) 4.07
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother (2000) 4.03
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis (2011) 2.99
T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis (2015) 2.28
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clin Infect Dis (2014) 2.24
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03
Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis (2009) 1.91
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2011) 1.69
The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med (1982) 1.65
Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J Clin Microbiol (1998) 1.36
Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis (2006) 1.23
Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol (2007) 1.19
Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One (2012) 1.09
Identification of fungal microorganisms by MALDI-TOF mass spectrometry. Biotechnol Adv (2013) 1.01
Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/Alert FN blood culture vials for the detection of candidemia. Diagn Microbiol Infect Dis (2012) 1.00
Invasive fungal infections in renal transplant recipients. Exp Clin Transplant (2011) 0.98
Cryptococcosis. Infect Dis Clin North Am (2016) 0.96
Two specific strains of Histoplasma capsulatum causing mucocutaneous manifestations of histoplasmosis: preliminary analysis of a frequent manifestation of histoplasmosis in southern Brazil. Mycopathologia (2008) 0.94
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan. J Antimicrob Chemother (2016) 0.93
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis (2014) 0.93
Histoplasmosis after solid organ transplant. Clin Infect Dis (2013) 0.92
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant (2010) 0.91
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect (2008) 0.91
Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program. PLoS One (2016) 0.90
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing. Clin Infect Dis (2015) 0.88
Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities. Emerg Infect Dis (2017) 0.86
Fatal peritonitis due to Trichoderma sp. in a patient undergoing continuous ambulatory peritoneal dialysis. Mycoses (2003) 0.84
Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation (2010) 0.82
Canavanine resistance in Cryptococcus neoformans. Antimicrob Agents Chemother (1986) 0.82
MALDI-TOF mass spectrometry: any use for Aspergilli? Mycopathologia (2014) 0.82
Cryptococcal cellulitis in a renal transplant patient. Nephrol Dial Transplant (2005) 0.80
Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS One (2014) 0.80
LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY. Rev Inst Med Trop Sao Paulo (2015) 0.79
Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev (2015) 0.79
ECIL 3-2009 update guidelines for antifungal management. Bone Marrow Transplant (2011) 0.79
Republished: The clinical spectrum of pulmonary aspergillosis. Postgrad Med J (2015) 0.78
Cryptococcal infection presenting as cellulitis in a renal transplant recipient. Transpl Infect Dis (2008) 0.77
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents (2015) 0.77
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report. Transpl Infect Dis (2014) 0.77
Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients. Mycopathologia (2016) 0.76
Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration? Med Mycol (2016) 0.76
Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations. J Clin Microbiol (2016) 0.76
Different risk factors for candidemia occur for Candida species belonging to the C. parapsilosis complex. Med Mycol (2014) 0.76
Has Aspergillus PCR Come to the Age of Maturity? Mycopathologia (2016) 0.76
Histoplasmosis-Associated Hospitalizations in the United States, 2001-2012. Open Forum Infect Dis (2016) 0.75